HCT Regenerative is the first company in Taiwan to focus on processing human tissue to provide orthobiologics and regenerative biomaterials for clinical use.
Our mission is to develop advanced human cellular and tissue based products (HCT/Ps) to improve patients' quality of life.
We are the first and only known company in Asia to process and bank human amniotic tissue, rich in growth factors and cytokines, and provide it for clinical use.
The products we develop and manufacture can be utilized in orthopedics, neurosurgery, sports medicine, ophthalmology, plastic surgery, wound management, dental, and cosmetics.
HCT Regenerative is approved by the TFDA and we are the only establishment in Taiwan to be accredited by the American Association of Tissue Banks (AATB).
Our management team has years of experience and extensive connections both in Taiwan and in the United States to the tissue banking and healthcare community.
Learn more about HCT Regenerative's quality assurance process.
...to manufacture advanced human cellular tissue based products (HCT/Ps) to improve patients' quality of life.